Literature DB >> 6972365

Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after x-irradiation.

F Zampetti-Bosseler, D Scott.   

Abstract

We recently showed (Scott and Zampetti-Bosseler 1980) that X-ray sensitive mouse lymphoma cells sustain more chromosome damage, mitotic delay and spindle defects than X-ray resistant cells. We proposed that (a) chromosome aberrations contribute much more to lethality than spindle defects, and (b) that DNA lesions are less effectively repaired in the sensitive cells and give rise to more G2 mitotic delay and chromosome aberrations. Our present results on human fibroblasts with reported differential sensitivity to ionizing radiation (i.e. normal donors and patients with ataxia telangiectasia and retinoblastoma) support the first hypothesis since we observed a positive correlation between chromosome aberration frequencies and cell killing and no induced spindle defects. Our second hypothesis is however not substantiated since X-ray sensitive fibroblasts from the ataxia patient suffered less mitotic delay than cells from normal donors. A common lesion for mitotic delay and chromosome aberrations can still be assumed by adopting the hypothesis of Painter and Young (1981) that the defect in ataxia cells is not in repair but in a failure of DNA damage to initiate mitotic delay. In contrast to other reports, we found the retinoblastoma cells to be of normal radiation sensitivity (cell killing and aberration).

Entities:  

Mesh:

Year:  1981        PMID: 6972365     DOI: 10.1080/09553008114550651

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  36 in total

1.  Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation.

Authors:  B Xu; M B Kastan
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype.

Authors:  N Zhang; P Chen; K K Khanna; S Scott; M Gatei; S Kozlov; D Watters; K Spring; T Yen; M F Lavin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  G2 checkpoint control and G2 chromosomal radiosensitivity in cancer survivors and their families.

Authors:  Kevin K Cadwell; Gillian B Curwen; E Janet Tawn; Jeanette F Winther; John D Boice
Journal:  Mutagenesis       Date:  2010-11-02       Impact factor: 3.000

4.  Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.

Authors:  Gary P H Ho; Steven Margossian; Toshiyasu Taniguchi; Alan D D'Andrea
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

5.  Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.

Authors:  W K Kaufmann; J C Boyer; L L Estabrooks; S J Wilson
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

6.  Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation.

Authors:  Bo Xu; Seong-Tae Kim; Dae-Sik Lim; Michael B Kastan
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 7.  The human intra-S checkpoint response to UVC-induced DNA damage.

Authors:  William K Kaufmann
Journal:  Carcinogenesis       Date:  2009-09-30       Impact factor: 4.944

8.  Effect of caffeine in G2 on X-ray-induced chromosomal aberrations and mitotic inhibition in ataxia telangiectasia fibroblast and lymphoblastoid cells.

Authors:  K Hansson; A T Natarajan; B A Kihlman
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

9.  Occurrence of TRGV-BJ hybrid gene in SV40-transformed fibroblast cell lines.

Authors:  L P G D'Arce; C L Bassi; A L Fachin; G A S Passos; E T Sakamoto-Hojo
Journal:  Genetica       Date:  2009-01-14       Impact factor: 1.082

10.  Chromatid damage after G2 phase x-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair.

Authors:  R Parshad; K K Sanford; G M Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.